An increase in BAG-1 by PD-L1 confers resistance to tyrosine kinase inhibitor in non–small cell lung cancer via persistent activation of ERK signalling
European Journal of Cancer2017Vol. 85, pp. 95–105
Citations Over TimeTop 19% of 2017 papers
Related Papers
- → High-Throughput Analysis of Genome-Wide Receptor Tyrosine Kinase Expression in Human Cancers Identifies Potential Novel Drug Targets(2004)119 cited
- → Conservation and Early Expression of Zebrafish Tyrosine Kinases Support the Utility of Zebrafish as a Model for Tyrosine Kinase Biology(2012)21 cited
- → Receptor and nonreceptor tyrosine kinases in vascular biology of hypertension(2010)22 cited
- → ASH Annual Meeting 2012—Chronic Myeloid Leukemia Update(2013)1 cited
- → Abstract PL04-03: Cell signaling by receptor tyrosine kinases: From basic principles to cancer therapy(2012)1 cited